// App-Quantinova.ai

PB2022 : EXPLORING ALTERNATIVE DOSING REGIMENS OF SINGLE-AGENT BELANTAMAB MAFODOTIN ON SAFETY AND EFFICACY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DREAMM-14

Researchers

Presenter

  • Malin Hultcrantz

Principal Investigators

  • David Kleinman

  • Pavandeep Ghataorhe

  • Astrid Mckeown

  • Wei He

  • Thomas Ling

  • Roxanne C. Jewell

  • Julie Byrne

  • Laurie Eliason

  • Emma Scott

  • Joanna Opalinska

Medical Centers

  • GlaxoSmithKline, Research Triangle Park, NC

  • University of Rochester, Rochester, NY, United States

  • GlaxoSmithKline,Cambridge, MA,USA

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • GlaxoSmithKline,Cambridge, MA,États-unis

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • GlaxoSmithKline, Upper Providence, PA

  • GlaxoSmithKline,Research Triangle Park, NC,Estados Unidos

  • GlaxoSmithKline,Cambridge, MA,Estados Unidos

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • GlaxoSmithKline,London,Regno Unito

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • University of Rochester,Rochester,États-unis

  • Memorial Sloan Kettering Cancer Center,New York ,États-unis

  • GlaxoSmithKline,London,Royaume-uni

  • University of Rochester, Rochester, NY, United States

  • GlaxoSmithKline,Cambridge, MA,Verenigde Staten

  • GlaxoSmithKline, Research Triangle Park, NC

  • GlaxoSmithKline, London, United Kingdom

  • GlaxoSmithKline,Cambridge, MA,Verenigde Staten

  • GlaxoSmithKline, Research Triangle Park, NC

  • University of Rochester,Rochester, NY,Estados Unidos

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • Memorial Sloan Kettering Cancer Center,New York,Vereinigte Staaten

  • GlaxoSmithKline,Cambridge, MA,Verenigde Staten

  • GlaxoSmithKline,London,Vereinigtes Königreich

  • GlaxoSmithKline,Cambridge, MA,Stati Uniti

  • Memorial Sloan Kettering Cancer Center,New York,Vereinigte Staaten

  • GlaxoSmithKline,London,Storbritannien

  • GlaxoSmithKline,London,Verenigd Koninkrijk

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • University of Rochester, Rochester, NY, United States

  • University of Rochester, Rochester, NY

  • GlaxoSmithKline,London,Соединённое Королевство

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • GlaxoSmithKline,London,Regno Unito

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • University of Rochester,Rochester,États-unis

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • GSK2857916

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

  • Open Label

  • Multinational

Phase

  • II

Study Id's

  • NCT05064358

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved